22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
The Workers’ Minimum Standard of Housing and Amenities (Amendment) Act 2019 aims to expand the mini...
Read More >
According to the most recent statistics from the Canadian Cannabis Survey (CCS), 5% of people who us...
Read More >
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to spee?d on the...
Read More >
On February 6, 2020, the U.S. Court of Appeals for the Third Circuit upheld the Philadelphia Wage Eq...
Read More >
We previously reported on the San Antonio sick leave ordinance that was to become effective August 1...
Read More >
The New York state legislature has passed a bill that would allow employees making certain claims fo...
Read More >